October 2016 |
|
acrobat100516 CMS Acting Admin Slavitt Response Letter to Wyden on EpiPen Pricing |
September 2016 |
|
acrobat090216 Wyden Pallone Letter to HHS Sec Burwell on EpiPens and Medicaid |
June 2016 |
|
acrobat062316 Wyden Letter to Burwell regarding IPRCC |
|
acrobat061516 Wyden Letter to Acting DEA Admin Rosenberg on Fentanyl |
May 2016 |
|
acrobat052016 Wyden letter to CBP Commissioner Kerlikowske on Fentanyl |
|
acrobat051016 Wyden letter to Wyoming Sec of State Murray on Shell Companies |
|
acrobat051016 Wyden letter to Nevada Sec of State Cegavske on Shell Companies |
March 2016 |
|
acrobatBenjamin Gerritz |
February 2016 |
|
acrobat022516 Wyden Letter to Treasury Sec Lew on Terrorist Financing |
|
acrobat020416 Wyden Letter to IRS Commissioner Koskinen on Corporate Tax Gap |
|
acrobat020416 Wyden Letter to CDC Frieden Director on Opioids |
|
acrobat020516 Wyden Letter to HHS Sec Burwell Opioid Conflicts |
|
acrobat020516 Wyden Letter to HHS Sec Burwell on Opioid Conflicts of Interest |
|
acrobat020516 Wyden Letter to HHS Sec Burwell on Opioid Conflicts of Interest |
|
acrobat020419 Wyden Letter to CDC Director Frieden on Opioid Guidelines |